Abstract
We describe a male patient with dyskeratosis congenita who, in addition to the classic triad, also suffers from usual interstitial pneumonia. He was treated with methyl-prednisolone but it is not clear whether this had an influence on the course of the disease.
MeSH terms
-
Adult
-
Anti-Inflammatory Agents / therapeutic use
-
Disease Progression
-
Dyskeratosis Congenita / blood
-
Dyskeratosis Congenita / complications*
-
Dyskeratosis Congenita / diagnosis
-
Dyskeratosis Congenita / drug therapy
-
Humans
-
Lung Diseases, Interstitial / blood
-
Lung Diseases, Interstitial / complications*
-
Lung Diseases, Interstitial / diagnosis
-
Lung Diseases, Interstitial / drug therapy
-
Male
-
Methylprednisolone / therapeutic use
-
Respiratory Function Tests
-
Tomography, X-Ray Computed
Substances
-
Anti-Inflammatory Agents
-
Methylprednisolone